FTC noncompetes ban may create ‘dichotomy’ in health care space

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-22T09:44:47-04:00August 22nd, 2024|Latest News|0 Comments

The First-Ever Government Negotiation Process For Drugs Has Finished, But The Politics Are Ongoing

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-22T09:41:42-04:00August 22nd, 2024|Latest News|0 Comments

Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-22T09:40:45-04:00August 22nd, 2024|Latest News|0 Comments

Saul Anuzis: Hospital financial tactics threaten seniors’ health (and seniors vote)

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-21T09:28:40-04:00August 21st, 2024|Latest News|0 Comments

ONEONCOLOGY TO ACQUIRE LEADING UROLOGY SPECIALTY PRACTICE NETWORK

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-21T09:28:02-04:00August 21st, 2024|Latest News|0 Comments

APhA Campaign Aims to Spread Awareness About Harmful PBM Practices

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-21T09:02:23-04:00August 21st, 2024|Latest News|0 Comments